Showing 1 - 10 results of 10 for search 'Kasperzyk, J', query time: 0.02s
Refine Results
-
1
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice. by Baek, R, Kasperzyk, J, Platt, F, Seyfried, T
Published 2008Journal article -
2
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice by Baek, R, Kasperzyk, J, Platt, F, Seyfried, T
Published 2004Conference item -
3
Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice by Baek, R, Kasperzyk, J, Platt, F, Seyfried, T
Published 2005Conference item -
4
N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis by Kasperzyk, J, d'Azzo, A, Platt, F, Seyfried, T
Published 2004Conference item -
5
Effects of substrate deprivation therapy on brain lipids in neonatal GML storage disease mice by Kasperzyk, J, Hauser, E, D'Azzo, A, Platt, F, Seyfried, T
Published 2003Conference item -
6
-
7
Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice by Kasperzyk, J, Hauser, E, D'Azzo, A, Platt, F, Seyfried, T
Published 2002Conference item -
8
Therapeutic assessment of substrate deprivation using NB-DGJ in GM1 storage disease mice by Seyfried, T, Kasperzyk, J, Hauser, E, D'Azzo, A, Platt, F
Published 2003Conference item -
9
-
10
N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis. by Kasperzyk, J, El-Abbadi, M, Hauser, E, D'Azzo, A, Platt, F, Seyfried, T
Published 2004Journal article